Additional comments on Parkinson's disease

Por Lang, Anthony E.
Publicado em 1989

Pre-Motor Parkinson’s Disease: Concepts and Definitions

Por Siderowf, Andrew, Lang, Anthony E.
Publicado em 2012

Movement disorders : a comprehensive survey /

Por Weiner, William J., Lang, Anthony E.
Publicado em 1989

The Saskatchewan Movement Disorders Program: Commitment Pays Off

Por Lang, Anthony E., Stoessl, A. Jon
Publicado no Can J Neurol Sci (2015)

Extensive intracranial calcifications in a patient with a novel polymerase gamma-1 mutation

Por Sidiropoulos, Christos, Moro, Elena, Lang, Anthony E.
Publicado em 2013

Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease

Por AlDakheel, Amaal, Kalia, Lorraine V., Lang, Anthony E.
Publicado em 2013

Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome

Por Fasano, Alfonso, Borlot, Felippe, Lang, Anthony E., Andrade, Danielle M.
Publicado em 2014

Development of a Non-Motor Fluctuation Assessment Instrument for Parkinson Disease

Por Kleiner-Fisman, Galit, Martine, Rebecca, Lang, Anthony E., Stern, Matthew B.
Publicado em 2011

The prion hypothesis in Parkinson's disease: Braak to the future

Por Visanji, Naomi P, Brooks, Patricia L, Hazrati, Lili-Naz, Lang, Anthony E
Publicado em 2013

Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses

Por Mestre, Tiago A., Shah, Prakesh, Marras, Connie, Tomlinson, George, Lang, Anthony E.
Publicado em 2014

Uncovering the role of the insula in non-motor symptoms of Parkinson’s disease

Por Christopher, Leigh, Koshimori, Yuko, Lang, Anthony E., Criaud, Marion, Strafella, Antonio P.
Publicado em 2014

Vascular parkinsonism: Deconstructing a syndrome

Por Vizcarra, Joaquin A., Lang, Anthony E., Sethi, Kapil D, Espay, Alberto J.
Publicado no Mov Disord (2015)

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

Por deSouza, Ruth-Mary, Moro, Elena, Lang, Anthony E, Schapira, Anthony H V
Publicado em 2013

Deficits in the Mimicry of Facial Expressions in Parkinson's Disease

Por Livingstone, Steven R., Vezer, Esztella, McGarry, Lucy M., Lang, Anthony E., Russo, Frank A.
Publicado no Front Psychol (2016)

Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson’s Disease?

Por van Eimeren, Thilo, Ballanger, Bénédicte, Pellecchia, Giovanna, Miyasaki, Janis M, Lang, Anthony E, Strafella, Antonio P
Publicado em 2009

α-Synuclein oligomers and clinical implications for Parkinson disease

Por Kalia, Lorraine V., Kalia, Suneil K., McLean, Pamela J., Lozano, Andres M., Lang, Anthony E.
Publicado em 2012

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

Por Marek, Kenneth, Seibyl, John, Eberly, Shirley, Oakes, David, Shoulson, Ira, Lang, Anthony E., Hyson, Chris, Jennings, Danna
Publicado em 2014

Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis

Por Gasca-Salas, Carmen, Masellis, Mario, Khoo, Edwin, Shah, Binit B., Fisman, David, Lang, Anthony E., Kleiner-Fisman, Galit
Publicado no PLoS One (2016)

Contribution of insula in Parkinson's disease: A quantitative meta‐analysis study

Por Criaud, Marion, Christopher, Leigh, Boulinguez, Philippe, Ballanger, Benedicte, Lang, Anthony E., Cho, Sang S., Houle, Sylvain, Strafella, Antonio P.
Publicado no Hum Brain Mapp (2016)

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

Por Saeed, Usman, Compagnone, Jordana, Aviv, Richard I., Strafella, Antonio P., Black, Sandra E., Lang, Anthony E., Masellis, Mario
Publicado no Transl Neurodegener (2017)